Literature DB >> 33941616

Locus-Specific Characterization of Human Endogenous Retrovirus Expression in Prostate, Breast, and Colon Cancers.

Margaret C Steiner1, Jez L Marston2, Luis P Iñiguez2, Matthew L Bendall2, Katherine B Chiappinelli3,4, Douglas F Nixon2, Keith A Crandall5,4,6.   

Abstract

Human endogenous retroviruses (HERV) have been implicated in a variety of diseases including cancers. Recent research implicates HERVs in epigenetic gene regulation. Here we utilize a recently developed bioinformatics tool for identifying HERV expression at the locus-specific level to identify differential expression of HERVs in matched tumor-normal RNA-sequencing (RNA-seq) data from The Cancer Genome Atlas. Data from 52 prostate cancer, 111 breast cancer, and 24 colon cancer cases were analyzed. Locus-specific analysis identified active HERV elements and differentially expressed HERVs in prostate cancer, breast cancer, and colon cancer. In addition, differentially expressed host genes were identified across prostate, breast, and colon cancer datasets, respectively, including several involved in demethylation and antiviral response pathways, supporting previous findings regarding the pathogenic mechanisms of HERVs. A majority of differentially expressed HERVs intersected protein coding genes or lncRNAs in each dataset, and a subset of differentially expressed HERVs intersected differentially expressed genes in prostate, breast, and colon cancers, providing evidence towards regulatory function. Finally, patterns in HERV expression were identified in multiple cancer types, with 155 HERVs differentially expressed in all three cancer types. This analysis extends previous results identifying HERV transcription in cancer RNA-seq datasets to a locus-specific level, and in doing so provides a foundation for future studies investigating the functional role of HERV in cancers and identifies a number of novel targets for cancer biomarkers and immunotherapy. SIGNIFICANCE: Expressed human endogenous retroviruses are mapped at locus-specific resolution and linked to specific pathways to identify potential biomarkers and therapeutic targets in prostate, breast, and colon cancers. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33941616      PMCID: PMC8260468          DOI: 10.1158/0008-5472.CAN-20-3975

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   13.312


  49 in total

Review 1.  The evolutionary dynamics of human endogenous retroviral families.

Authors:  Norbert Bannert; Reinhard Kurth
Journal:  Annu Rev Genomics Hum Genet       Date:  2006       Impact factor: 8.929

2.  circlize Implements and enhances circular visualization in R.

Authors:  Zuguang Gu; Lei Gu; Roland Eils; Matthias Schlesner; Benedikt Brors
Journal:  Bioinformatics       Date:  2014-06-14       Impact factor: 6.937

3.  Regulatory evolution of innate immunity through co-option of endogenous retroviruses.

Authors:  Edward B Chuong; Nels C Elde; Cédric Feschotte
Journal:  Science       Date:  2016-03-04       Impact factor: 47.728

4.  Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences.

Authors:  Charlotte Soneson; Michael I Love; Mark D Robinson
Journal:  F1000Res       Date:  2015-12-30

5.  The immunomodulatory anticancer agent, RRx-001, induces an interferon response through epigenetic induction of viral mimicry.

Authors:  Hongjuan Zhao; Shoucheng Ning; Rosalie Nolley; Jan Scicinski; Bryan Oronsky; Susan J Knox; Donna M Peehl
Journal:  Clin Epigenetics       Date:  2017-01-19       Impact factor: 6.551

6.  Telescope: Characterization of the retrotranscriptome by accurate estimation of transposable element expression.

Authors:  Matthew L Bendall; Miguel de Mulder; Luis Pedro Iñiguez; Aarón Lecanda-Sánchez; Marcos Pérez-Losada; Mario A Ostrowski; R Brad Jones; Lubbertus C F Mulder; Gustavo Reyes-Terán; Keith A Crandall; Christopher E Ormsby; Douglas F Nixon
Journal:  PLoS Comput Biol       Date:  2019-09-30       Impact factor: 4.475

7.  The landscape of viral associations in human cancers.

Authors:  Marc Zapatka; Ivan Borozan; Daniel S Brewer; Murat Iskar; Adam Grundhoff; Malik Alawi; Nikita Desai; Holger Sültmann; Holger Moch; Colin S Cooper; Roland Eils; Vincent Ferretti; Peter Lichter
Journal:  Nat Genet       Date:  2020-02-05       Impact factor: 38.330

8.  Detection of Human Endogenous Retrovirus K (HERV-K) Transcripts in Human Prostate Cancer Cell Lines.

Authors:  Lorenzo Agoni; Chandan Guha; Jack Lenz
Journal:  Front Oncol       Date:  2013-07-09       Impact factor: 6.244

9.  TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data.

Authors:  Antonio Colaprico; Tiago C Silva; Catharina Olsen; Luciano Garofano; Claudia Cava; Davide Garolini; Thais S Sabedot; Tathiane M Malta; Stefano M Pagnotta; Isabella Castiglioni; Michele Ceccarelli; Gianluca Bontempi; Houtan Noushmehr
Journal:  Nucleic Acids Res       Date:  2015-12-23       Impact factor: 16.971

10.  Transcriptional Profiles from Paired Normal Samples Offer Complementary Information on Cancer Patient Survival--Evidence from TCGA Pan-Cancer Data.

Authors:  Xiu Huang; David F Stern; Hongyu Zhao
Journal:  Sci Rep       Date:  2016-02-03       Impact factor: 4.379

View more
  7 in total

1.  Epigenetic Therapies in Ovarian Cancer Alter Repetitive Element Expression in a TP53-Dependent Manner.

Authors:  James I McDonald; Noor Diab; Elisa Arthofer; Melissa Hadley; Tomas Kanholm; Uzma Rentia; Stephanie Gomez; Angela Yu; Erin E Grundy; Olivia Cox; Michael J Topper; Xiaoyun Xing; Pamela L Strissel; Reiner Strick; Ting Wang; Stephen B Baylin; Katherine B Chiappinelli
Journal:  Cancer Res       Date:  2021-08-25       Impact factor: 12.701

2.  Differential expression of an endogenous retroviral element [HERV-K(HML-6)] is associated with reduced survival in glioblastoma patients.

Authors:  Ashish H Shah; Vaidya Govindarajan; Tara T Doucet-O'Hare; Sarah Rivas; Leo Ampie; Catherine DeMarino; Yeshavanth Kumar Banasavadi-Siddegowda; Yong Zhang; Kory R Johnson; Fahad Almsned; Mark R Gilbert; John D Heiss; Avindra Nath
Journal:  Sci Rep       Date:  2022-04-27       Impact factor: 4.996

3.  H3K9 methylation drives resistance to androgen receptor-antagonist therapy in prostate cancer.

Authors:  Mehdi Baratchian; Ritika Tiwari; Sirvan Khalighi; Ankur Chakravarthy; Wei Yuan; Michael Berk; Jianneng Li; Amy Guerinot; Johann de Bono; Vladimir Makarov; Timothy A Chan; Robert H Silverman; George R Stark; Vinay Varadan; Daniel D De Carvalho; Abhishek A Chakraborty; Nima Sharifi
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-18       Impact factor: 12.779

4.  Specific human endogenous retroviruses predict metastatic potential in uveal melanoma.

Authors:  Matthew L Bendall; Jasmine H Francis; Alexander N Shoushtari; Douglas F Nixon
Journal:  JCI Insight       Date:  2022-05-09

Review 5.  The Role of The Tumor Microbiome in Tumor Development and Its Treatment.

Authors:  Yan Chen; Fa-Hong Wu; Peng-Qiang Wu; Hong-Yun Xing; Tao Ma
Journal:  Front Immunol       Date:  2022-07-15       Impact factor: 8.786

Review 6.  Prostate Microbiota and Prostate Cancer: A New Trend in Treatment.

Authors:  Bangwei Che; Wenjun Zhang; Shenghan Xu; Jingju Yin; Jun He; Tao Huang; Wei Li; Ying Yu; Kaifa Tang
Journal:  Front Oncol       Date:  2021-12-10       Impact factor: 6.244

7.  Expression of Endogenous Retroviral RNA in Prostate Tumors has Prognostic Value and Shows Differences among Americans of African Versus European/Middle Eastern Ancestry.

Authors:  Vinay Kumar; Michael McClelland; James Nguyen; Gabriela De Robles; Michael Ittmann; Patricia Castro; Dan Mercola; Zhenyu Jia; Farah Rahmatpanah
Journal:  Cancers (Basel)       Date:  2021-12-17       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.